Current research with psychedelics is yielding promising results in the treatment of trauma, end of life anxiety, depression and addiction. All indications are that many psychedelics (as they are known today) will be legally available for use, balanced for both risk and benefit.

However, serious negative effects are documented from illegal and recreational use of psychedelics. This is especially true for people with pre-existing mental health challenges or at-risk members of our society. We are advocates of the healing potential that psychedelics are being shown to have in legal therapeutic and ceremonial settings. To learn more regarding the research and advances towards the legalization of psychedelics in Canada, as well as clinical trials, we recommend following some of the sites below.

To Find a Clinical Trial to Participate in:

• NCBI – WWW Error Blocked Diagnostic
• Participate in a Trial – Multidisciplinary Association for Psychedelic Studies – MAPS
• PAC – Clinical Trials

Our primary focus is about harm reduction and post-consumption management under the ethic of harm reduction. We want to ensure safety.

Do We Prescribe or Administer Psychedelics?

Does THERAPY help with non-ordinary states and altered states of consciousness?

To be clear, non ordinary states/altered states of consciousness can also be experienced without substances. There are degrees. For instance, holotropic breathwork, shamanic and Indigeneous healing ceremonies, intentional and guided dreaming states, hypnotherapy, sound and light therapies, have all been know to do this.

So yes, therapy can and does help with all of these states. As stated, we take a harm reduction approach to promote education and safety in all non-ordinary states. We offer a safe, confidential space to process, explore, and share challenges and insights that may have happened in non-ordinary states and the potential for the personal transformation that they offer. This includes all the examples listed above, to name only a few non-ordinary states that you may want to explore in a session.

Emerging Changes

Wallace Murray & Associates are focusing on educational and training opportunities in psychedelic and plant medicine support and integration along with our continued learning into many other non-ordinary states. With the emergence of psychedelics and plant medicine as being a part of clinical healing modalities, we feel that increased focus on psychedelic harm reduction and psychedelic crisis response is the best way we can be of service to this emerging field at this time.

As legislation in Canada is evolving and different jurisdictions allow for psychedelics, we are doing our best to stay current. At present, I have completed both a Psychedelic Therapy Training Program Certificate as well as an Advanced Psychedelic-Assisted Therapy (PaT) Training Certificate. I have also completed the Microprogram in Psychedelics & Spirituality Studies at the University of Ottawa. I am presently completing a Masters in the same department.

Our future aim is to continue learning within clinical trials, from knowledge keepers in these areas, and to provide complex individual treatment plans in our Canadian partner multidisciplinary clinics as well as participate in and offer retreats in legal jurisdictions.

Special Access Program (SAP)

We currently provide Psilocybin Assisted therapy and MDMA Assisted therapy for those with SAP approval, Ketamine (KAP) assisted therapy, as well as Psychedelic-Assisted therapy for those with SAP approval.

We also assist eligible participants to access SAP approval from Health Canada. We provide for Health Canada SAP approved individuals aftercare.

Here are some of the reasons why our clients choose us:

• We are focused on improving access to integrative and regulated care. We align ourselves with the existing and emerging evidence of the efficacy of Psychedelic-Assisted Therapy treatments.

• We believe in an interdisciplinary approach so have partnered with resources to deliver comprehensive support. Our approach is to follow the highest safety standards and optimal therapeutic efficacy in the delivery of Psychedelic-Assisted Therapy.

• We work and study in this area, and have a support network and infrastructure, as well as a robust network of therapists and clinicians, so as to bridge regulatory gaps as they arise.

• We like to laugh and smile, as we know how therapeutic that can be!